advertisement

---

Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 17

Showing records 1 to 17 | Display all abstracts in Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie

118313 Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Liao J
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 170: 116042

---

117976 A novel HDAC8 inhibitor H7E exerts retinoprotective effects against glaucomatous injury via ameliorating aberrant Müller glia activation and oxidative stress
Wu LH; Cheng YW
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 174: 116538

---

118313 Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Lai Z
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 170: 116042

---

117976 A novel HDAC8 inhibitor H7E exerts retinoprotective effects against glaucomatous injury via ameliorating aberrant Müller glia activation and oxidative stress
Lin FL
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 174: 116538

---

118313 Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Huang G
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 170: 116042

---

117976 A novel HDAC8 inhibitor H7E exerts retinoprotective effects against glaucomatous injury via ameliorating aberrant Müller glia activation and oxidative stress
Hsu KC
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 174: 116538

---

118313 Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Lin J
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 170: 116042

---

117976 A novel HDAC8 inhibitor H7E exerts retinoprotective effects against glaucomatous injury via ameliorating aberrant Müller glia activation and oxidative stress
Wang MH
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 174: 116538

---

118313 Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Huang W
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 170: 116042

---

117976 A novel HDAC8 inhibitor H7E exerts retinoprotective effects against glaucomatous injury via ameliorating aberrant Müller glia activation and oxidative stress
Yen JL
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 174: 116538

---

118313 Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Qin Y
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 170: 116042

---

117976 A novel HDAC8 inhibitor H7E exerts retinoprotective effects against glaucomatous injury via ameliorating aberrant Müller glia activation and oxidative stress
Wang TJ
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 174: 116538

---

118313 Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Chen Q; Hu Y
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 170: 116042

---

117976 A novel HDAC8 inhibitor H7E exerts retinoprotective effects against glaucomatous injury via ameliorating aberrant Müller glia activation and oxidative stress
Lin TE; Liu YC
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 174: 116538

---

118313 Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Cheng Q; Jiang L
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 170: 116042

---

117976 A novel HDAC8 inhibitor H7E exerts retinoprotective effects against glaucomatous injury via ameliorating aberrant Müller glia activation and oxidative stress
Huang WJ; Hsiao G
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 174: 116538

---

118313 Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Cui L; Zhong H; Li M; Wei Y; Xu F
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 170: 116042

---